...ORY-1001 to treat AML. GlaxoSmithKline plc anticipates starting clinical trials of its GSK2879552 this year. Frontier Pharma Inc....
...Washington, D.C. Huntsman Cancer Institute at the University of Utah , Salt Lake City, Utah Frontier Pharma Inc....

...the company and was a co-author on the 2004 paper that first described LSD1's function. Frontier Pharma Inc....
...London, U.K. Epi Pharmaceuticals Inc. , no location yet EpiTherapeutics ApS , Copenhagen, Denmark Frontier Pharma Inc....

...doi:10.1038/scibx.2009.1683 Published online Dec. 3, 2009 Companies and Institutions Mentioned Duke University , Durham, N.C. Frontier Pharma Inc....
...shown that lysine-specific demethylase-1 could be a good target to treat herpes infections. 1 Separately, Frontier Pharma Inc....
...Meanwhile, Frontier Pharma will take the lead in preclinical studies of the compounds to treat cancer. Frontier Pharma...